FI954213A - Kasvainten vastaisia koostumuksia ja hoitomenetelmiä - Google Patents
Kasvainten vastaisia koostumuksia ja hoitomenetelmiä Download PDFInfo
- Publication number
- FI954213A FI954213A FI954213A FI954213A FI954213A FI 954213 A FI954213 A FI 954213A FI 954213 A FI954213 A FI 954213A FI 954213 A FI954213 A FI 954213A FI 954213 A FI954213 A FI 954213A
- Authority
- FI
- Finland
- Prior art keywords
- tumor
- treatment methods
- indolinesulfonamide
- indolesulfonamide
- chem
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2909593A | 1993-03-10 | 1993-03-10 | |
PCT/US1994/002606 WO1994020101A1 (en) | 1993-03-10 | 1994-03-10 | Antitumor compositions and methods of treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
FI954213A0 FI954213A0 (fi) | 1995-09-08 |
FI954213A true FI954213A (fi) | 1995-10-11 |
Family
ID=21847185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954213A FI954213A (fi) | 1993-03-10 | 1995-09-08 | Kasvainten vastaisia koostumuksia ja hoitomenetelmiä |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0614887B1 (fi) |
JP (1) | JPH08507532A (fi) |
KR (1) | KR960700710A (fi) |
AT (1) | ATE154345T1 (fi) |
AU (1) | AU687042B2 (fi) |
BR (1) | BR9405997A (fi) |
CA (1) | CA2157801A1 (fi) |
CZ (1) | CZ232695A3 (fi) |
DE (1) | DE69403695T2 (fi) |
DK (1) | DK0614887T3 (fi) |
ES (1) | ES2102774T3 (fi) |
FI (1) | FI954213A (fi) |
GR (1) | GR3023827T3 (fi) |
HU (1) | HU218660B (fi) |
NO (1) | NO953557L (fi) |
NZ (1) | NZ263080A (fi) |
PL (1) | PL310558A1 (fi) |
RU (1) | RU2127259C1 (fi) |
WO (1) | WO1994020101A1 (fi) |
ZA (1) | ZA941500B (fi) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69708340T2 (de) * | 1996-08-22 | 2002-05-16 | Dong Wha Pharm Ind Co Ltd | Arylsulfonylimidazolon-derivate als antitumormittel |
DE19919793A1 (de) | 1999-04-30 | 2000-11-02 | Bayer Ag | Neue Sulfonamide |
ATE375978T1 (de) * | 2002-11-22 | 2007-11-15 | Lilly Co Eli | Benzoylsulfonamide als antitumor-mittel |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1240866B (de) * | 1961-06-29 | 1967-05-24 | Heyden Chem Fab | Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen |
US5116874A (en) * | 1985-09-23 | 1992-05-26 | Eli Lilly And Company | Anti-tumor method and compounds |
IL80032A (en) * | 1985-09-23 | 1992-07-15 | Lilly Co Eli | Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them |
CA1331464C (en) * | 1987-05-12 | 1994-08-16 | Eli Lilly And Company | Anti-tumor method and compounds |
NZ238911A (en) * | 1990-07-17 | 1993-10-26 | Lilly Co Eli | Furyl, pyrrolyl and thienyl sulphonyl urea derivatives, pharmaceutical compositions and intermediates therefor |
US5169860A (en) * | 1992-03-13 | 1992-12-08 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
-
1994
- 1994-03-03 ZA ZA941500A patent/ZA941500B/xx unknown
- 1994-03-09 DK DK94301671.7T patent/DK0614887T3/da active
- 1994-03-09 DE DE69403695T patent/DE69403695T2/de not_active Expired - Fee Related
- 1994-03-09 AT AT94301671T patent/ATE154345T1/de not_active IP Right Cessation
- 1994-03-09 ES ES94301671T patent/ES2102774T3/es not_active Expired - Lifetime
- 1994-03-09 EP EP94301671A patent/EP0614887B1/en not_active Expired - Lifetime
- 1994-03-10 JP JP6520310A patent/JPH08507532A/ja active Pending
- 1994-03-10 BR BR9405997A patent/BR9405997A/pt not_active Application Discontinuation
- 1994-03-10 AU AU63638/94A patent/AU687042B2/en not_active Ceased
- 1994-03-10 CZ CZ952326A patent/CZ232695A3/cs unknown
- 1994-03-10 PL PL94310558A patent/PL310558A1/xx unknown
- 1994-03-10 RU RU95122639A patent/RU2127259C1/ru active
- 1994-03-10 WO PCT/US1994/002606 patent/WO1994020101A1/en not_active Application Discontinuation
- 1994-03-10 HU HU9502627A patent/HU218660B/hu not_active IP Right Cessation
- 1994-03-10 CA CA002157801A patent/CA2157801A1/en not_active Abandoned
- 1994-03-10 NZ NZ263080A patent/NZ263080A/en unknown
- 1994-03-10 KR KR1019950703798A patent/KR960700710A/ko not_active Application Discontinuation
-
1995
- 1995-09-08 FI FI954213A patent/FI954213A/fi unknown
- 1995-09-08 NO NO953557A patent/NO953557L/no unknown
-
1997
- 1997-06-19 GR GR970401465T patent/GR3023827T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
BR9405997A (pt) | 1995-12-19 |
JPH08507532A (ja) | 1996-08-13 |
AU687042B2 (en) | 1998-02-19 |
NO953557D0 (no) | 1995-09-08 |
DE69403695T2 (de) | 1997-10-30 |
CZ232695A3 (en) | 1996-01-17 |
ZA941500B (en) | 1995-09-04 |
NO953557L (no) | 1995-11-02 |
NZ263080A (en) | 1996-12-20 |
DK0614887T3 (da) | 1997-10-20 |
WO1994020101A1 (en) | 1994-09-15 |
GR3023827T3 (en) | 1997-09-30 |
EP0614887A1 (en) | 1994-09-14 |
KR960700710A (ko) | 1996-02-24 |
AU6363894A (en) | 1994-09-26 |
HUT72897A (en) | 1996-06-28 |
PL310558A1 (en) | 1995-12-27 |
ES2102774T3 (es) | 1997-08-01 |
HU9502627D0 (en) | 1995-11-28 |
CA2157801A1 (en) | 1994-09-15 |
RU2127259C1 (ru) | 1999-03-10 |
HU218660B (hu) | 2000-10-28 |
EP0614887B1 (en) | 1997-06-11 |
FI954213A0 (fi) | 1995-09-08 |
DE69403695D1 (de) | 1997-07-17 |
ATE154345T1 (de) | 1997-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9710292B (en) | Atherosclerosis treatment | |
ATE343367T1 (de) | Photostabile organische sonnenschutzmittel mit antioxidativen eigenschaften und zusammensetzungen damit | |
IL110151A0 (en) | Amide and urea derivatives and pharmaceutical compositions containing the same | |
HUT59394A (en) | Process for producing piperazine derivatives and pharmaceutical compositions comprising same | |
BR9305164A (pt) | Composto, formulação farmacêutica e processo para preparar um composto | |
PL309874A1 (en) | Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives | |
DK0532515T3 (da) | Fremstilling af substituerede piperidiner | |
AU4872793A (en) | New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them | |
FI954213A0 (fi) | Kasvainten vastaisia koostumuksia ja hoitomenetelmiä | |
GR3023757T3 (en) | Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents. | |
IT1213301B (it) | Composizioni per il trattamento del le sindromi da ischemia e riperfusione | |
HUT70761A (en) | Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof | |
GB2245566A (en) | Carbamoyl derivatives of alkanolamines and antistress-action agent for plant-growth regulation based thereon | |
GR3005900T3 (fi) | ||
PT77774A (fr) | Nouveaux derives de la pyrrolidine leur preparation et les medicaments qui les contiennent | |
ZA924888B (en) | Process for the synthesis of enantiomers of 3-aminochroman compounds | |
DK0421668T3 (da) | 1,4-dihydro-4-oxo-3-quinolinderivater som selektivt toksiske, antibakterielle midler til pattedyr | |
EP0443474A3 (en) | 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents | |
GR3004321T3 (fi) |